Cargando…
The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features
Cutaneous vasculitis may be associated with malignancies, and may behave as a paraneoplastic syndrome. This association has been reported in a variable proportion of patients depending on population selection. We conducted the current study to assess the frequency, clinical features, treatment, and...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553993/ https://www.ncbi.nlm.nih.gov/pubmed/24145696 http://dx.doi.org/10.1097/MD.0000000000000009 |
_version_ | 1782387988591804416 |
---|---|
author | Loricera, Javier Calvo-Río, Vanesa Ortiz-Sanjuán, Francisco González-López, Marcos A. Fernández-Llaca, Hector Rueda-Gotor, Javier Gonzalez-Vela, Maria C. Alvarez, Lino Mata, Cristina González-Lamuño, Domingo Martínez-Taboada, Victor M. González-Gay, Miguel A. Blanco, Ricardo |
author_facet | Loricera, Javier Calvo-Río, Vanesa Ortiz-Sanjuán, Francisco González-López, Marcos A. Fernández-Llaca, Hector Rueda-Gotor, Javier Gonzalez-Vela, Maria C. Alvarez, Lino Mata, Cristina González-Lamuño, Domingo Martínez-Taboada, Victor M. González-Gay, Miguel A. Blanco, Ricardo |
author_sort | Loricera, Javier |
collection | PubMed |
description | Cutaneous vasculitis may be associated with malignancies, and may behave as a paraneoplastic syndrome. This association has been reported in a variable proportion of patients depending on population selection. We conducted the current study to assess the frequency, clinical features, treatment, and outcome of paraneoplastic vasculitis in a large unselected series of 766 patients with cutaneous vasculitis diagnosed at a single university hospital. Sixteen patients (10 men and 6 women; mean age ± standard deviation, 67.94 ± 14.20 yr; range, 40–85 yr) presenting with cutaneous vasculitis were ultimately diagnosed as having an underlying malignancy. They constituted 3.80% of the 421 adult patients. There were 9 hematologic and 7 solid underlying malignancies. Skin lesions were the initial clinical presentation in all of them, and the median interval from the onset of cutaneous vasculitis to the diagnosis of the malignancy was 17 days (range, 8–50 d). The most frequent skin lesions were palpable purpura (15 patients). Other clinical manifestations included constitutional syndrome (10 patients) and arthralgia and/or arthritis (4 cases). Hematologic cytopenias (11 cases) as well as immature peripheral blood cells (6 cases) were frequently observed in the full blood cell count, especially in those with vasculitis associated with hematologic malignancies. Specific treatment for vasculitis was prescribed in 10 patients; nonsteroidal antiinflammatory drugs (4 patients), corticosteroids (3 patients), chloroquine (1 patient), antihistamines (1 patient), and cyclophosphamide (1 patient). Ten patients died due to the malignancy and 6 patients recovered following malignancy therapy. Patients with paraneoplastic vasculitis were older, more frequently had constitutional syndrome, and less frequently had organ damage due to the vasculitis than the remaining patients with cutaneous vasculitis. In summary, cutaneous paraneoplastic vasculitis is an entity not uncommonly encountered by clinicians. The most common underlying malignancy is generally hematologic. In these cases the presence of cytopenias and immature cells may be red flags for the diagnosis of cancer. In patients with paraneoplastic cutaneous vasculitis, the prognosis depends on the underlying neoplasia. |
format | Online Article Text |
id | pubmed-4553993 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-45539932015-10-27 The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features Loricera, Javier Calvo-Río, Vanesa Ortiz-Sanjuán, Francisco González-López, Marcos A. Fernández-Llaca, Hector Rueda-Gotor, Javier Gonzalez-Vela, Maria C. Alvarez, Lino Mata, Cristina González-Lamuño, Domingo Martínez-Taboada, Victor M. González-Gay, Miguel A. Blanco, Ricardo Medicine (Baltimore) Original Study Cutaneous vasculitis may be associated with malignancies, and may behave as a paraneoplastic syndrome. This association has been reported in a variable proportion of patients depending on population selection. We conducted the current study to assess the frequency, clinical features, treatment, and outcome of paraneoplastic vasculitis in a large unselected series of 766 patients with cutaneous vasculitis diagnosed at a single university hospital. Sixteen patients (10 men and 6 women; mean age ± standard deviation, 67.94 ± 14.20 yr; range, 40–85 yr) presenting with cutaneous vasculitis were ultimately diagnosed as having an underlying malignancy. They constituted 3.80% of the 421 adult patients. There were 9 hematologic and 7 solid underlying malignancies. Skin lesions were the initial clinical presentation in all of them, and the median interval from the onset of cutaneous vasculitis to the diagnosis of the malignancy was 17 days (range, 8–50 d). The most frequent skin lesions were palpable purpura (15 patients). Other clinical manifestations included constitutional syndrome (10 patients) and arthralgia and/or arthritis (4 cases). Hematologic cytopenias (11 cases) as well as immature peripheral blood cells (6 cases) were frequently observed in the full blood cell count, especially in those with vasculitis associated with hematologic malignancies. Specific treatment for vasculitis was prescribed in 10 patients; nonsteroidal antiinflammatory drugs (4 patients), corticosteroids (3 patients), chloroquine (1 patient), antihistamines (1 patient), and cyclophosphamide (1 patient). Ten patients died due to the malignancy and 6 patients recovered following malignancy therapy. Patients with paraneoplastic vasculitis were older, more frequently had constitutional syndrome, and less frequently had organ damage due to the vasculitis than the remaining patients with cutaneous vasculitis. In summary, cutaneous paraneoplastic vasculitis is an entity not uncommonly encountered by clinicians. The most common underlying malignancy is generally hematologic. In these cases the presence of cytopenias and immature cells may be red flags for the diagnosis of cancer. In patients with paraneoplastic cutaneous vasculitis, the prognosis depends on the underlying neoplasia. Wolters Kluwer Health 2013-11 2013-11-14 /pmc/articles/PMC4553993/ /pubmed/24145696 http://dx.doi.org/10.1097/MD.0000000000000009 Text en Copyright © 2013 by Lippincott Williams & Wilkins |
spellingShingle | Original Study Loricera, Javier Calvo-Río, Vanesa Ortiz-Sanjuán, Francisco González-López, Marcos A. Fernández-Llaca, Hector Rueda-Gotor, Javier Gonzalez-Vela, Maria C. Alvarez, Lino Mata, Cristina González-Lamuño, Domingo Martínez-Taboada, Victor M. González-Gay, Miguel A. Blanco, Ricardo The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features |
title | The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features |
title_full | The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features |
title_fullStr | The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features |
title_full_unstemmed | The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features |
title_short | The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population: Incidence and Clinical Features |
title_sort | spectrum of paraneoplastic cutaneous vasculitis in a defined population: incidence and clinical features |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553993/ https://www.ncbi.nlm.nih.gov/pubmed/24145696 http://dx.doi.org/10.1097/MD.0000000000000009 |
work_keys_str_mv | AT loricerajavier thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT calvoriovanesa thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT ortizsanjuanfrancisco thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezlopezmarcosa thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT fernandezllacahector thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT ruedagotorjavier thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezvelamariac thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT alvarezlino thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT matacristina thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezlamunodomingo thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT martineztaboadavictorm thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezgaymiguela thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT blancoricardo thespectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT loricerajavier spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT calvoriovanesa spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT ortizsanjuanfrancisco spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezlopezmarcosa spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT fernandezllacahector spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT ruedagotorjavier spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezvelamariac spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT alvarezlino spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT matacristina spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezlamunodomingo spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT martineztaboadavictorm spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT gonzalezgaymiguela spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures AT blancoricardo spectrumofparaneoplasticcutaneousvasculitisinadefinedpopulationincidenceandclinicalfeatures |